Dori Thomas-Karyat

Dori Thomas-Karyat is a highly accomplished individual with a strong educational background. She pursued a Doctor of Philosophy in Immunology at Washington University School of Medicine in St. Louis, and a Bachelor of Science in Biology at the University of Illinois at Urbana-Champaign.

Professionally, Dori has held various key positions, showcasing her leadership skills and expertise. She is currently serving as the Chief Executive Officer at Synthis, a role where she drives the strategic direction and overall success of the organization. Prior to this, Dori was the Founder of Synthis, demonstrating her entrepreneurial spirit and innovative thinking.

Dori has also been recognized for her contributions to the field. She was a Fellow at the Bio and Health Tech NYC Entrepreneurship Lab in 2018, highlighting her involvement in cutting-edge technology and healthcare initiatives. Additionally, she received the Women In Bio Founders Scholarship in 2017, underscoring her commitment to supporting women in the field of life sciences.

With a solid scientific background, Dori has significant industry experience. She has worked as a Principal Scientist and Senior Research Scientist at Roche, where she contributed to research and development efforts. Prior to her time at Roche, she was a Research Scientist at Abbott, showcasing her diverse skill set and adaptability within the pharmaceutical industry.

Furthermore, Dori has engaged in impactful research during her career. She served as a Postdoctoral Fellow at the prestigious Memorial Sloan Kettering Cancer Center, illustrating her dedication to advancing knowledge in the field of cancer research.

In summary, Dori Thomas-Karyat is a versatile professional with a deep understanding of immunology and biology. Her impressive track record in executive leadership, entrepreneurship, and scientific research positions her as a key figure in the life sciences industry.